Novel equation for estimating resting energy expenditure in patients with chronic kidney disease

Background: In chronic kidney disease (CKD), determining energy expenditure is the precondition for recommending energy intake in nutrition management. Objectives: We aimed to develop and validate a resting energy expenditure (REE) equation for patients with CKD. Methods: This cross-sectional study enrolled 300 patients with CKD (stages 3-5) according to inclusion and exclusion criteria. Stepwise linear regression analysis was used to derive a new REE equation (eREE-CKD) according to actual REE (aREE) measured using indirect calorimetry in the development dataset. The eREE-CKD value was then validated with aREE in the validation dataset and compared with values from existing equations obtained in general populations, namely, the Harris-Benedict, Mifflin, WHO, and Schofield equations in terms of bias, precision, and accuracy. Results: The eREE-CKD equation: eREE-CKD (kcal) = (1 if male; 0 if female) x 106.0 - [1 if diabetes mellitus (DM); 0 if non-DM] x 51.6 - 4.7 x age (y) + 13.1 x weight (kg) + 645.5 (R-2 = 0.779). The bias, precision, and accuracy (percentage of estimates that differed >20% from the measured REE) of the eREE-CKD equation were -0.4 (IQR: -29.8, 23.8) kcal, 98.4 (IQR: 79.5, 116.6) kcal, and 5.4%, respectively with indirect calorimetry as the reference method. Both bias and precision of the eREE-CKD were significantly better than the Harris-Benedict, WHO, and Schofield equations (P < 0.001) and similar to the Mifflin equation (P = 0.125 for bias and 0.268 for precision). Accuracy of the eREE-CKDwas significantly better than the Harris-Benedict, WHO, Mifflin, and Schofield equations (P < 0.001). Bias, precision, and accuracy of the eREE-CKD equation were consistent when applied to subgroups categorized according to high-sensitivity C-reactive protein concentrations and CKD stages, respectively. Conclusions: The eREE-CKD equation using age, sex, weight, and DM data could serve as a reliable tool for estimating REE in patients with CKD.